SCHEMBL4873098

SCHEMBL4873098

OCc1ccccc1-c1ccc(C(F)(F)F)s1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.41
HPGD P15428 1/20 0.41
PDK2 Q15119 4/20 0.40
HIF1A Q16665 1/20 0.39
EPAS1 Q99814 1/20 0.39
TRPV3 Q8NET8 1/20 0.37
DAO P14920 1/20 0.37
PDCD1 Q15116 1/20 0.36
CD274 Q9NZQ7 1/20 0.36
NPFFR1 Q9GZQ6 1/20 0.35
NPFFR2 Q9Y5X5 1/20 0.35
ERCC5 P28715 1/20 0.34
FEN1 P39748 1/20 0.34
KRAS P01116 1/20 0.33
SOS1 Q07889 1/20 0.33
HDAC6 Q9UBN7 1/20 0.33
APOBEC3G Q9HC16 1/20 0.33
TLR8 Q9NR97 1/20 0.33
PTGER1 P34995 1/20 0.33
PTGER4 P35408 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25094675 0.83 PDCD1 (0.40) HPGDPDK2HIF1AEPAS1PDCD1
SCHEMBL19439599 0.77 DAO (0.48) ALDH1A1HPGDTRPV3DAOERCC5
SCHEMBL25078757 0.76 HIF1A (0.45) ALDH1A1HPGDHIF1AEPAS1PDCD1
SCHEMBL24801870 0.75 PDCD1 (0.46) ALDH1A1HPGDHIF1AEPAS1PDCD1
SCHEMBL16801819 0.74 DAO (0.46) ALDH1A1HPGDTRPV3DAOERCC5
SCHEMBL2182300 0.74 CA12 (0.41) ALDH1A1HPGDDAO
SCHEMBL30755514 0.71 ALDH1A1 (0.54) ALDH1A1HPGDDAOERCC5FEN1
SCHEMBL20656178 0.71 PDCD1 (0.40) PDK2HIF1AEPAS1PDCD1CD274
SCHEMBL25094109 0.70 PTGER1 (0.36) ALDH1A1HPGDPDK2HIF1AEPAS1
SCHEMBL1221964 0.70 PDCD1 (0.54) PDK2PDCD1CD274APOBEC3G

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7351725-B2 N-(benzyl)aminoalkylcarboxylates, phosphinates, phosphonates and tetrazoles as Edg receptor agonists MERCK & CO., INC. (US) 2008-04-01 US disclosed
US-20050020837-A1 N-(benzyl)aminoalkylcarboxylates, phosphinates, phosphonates and tetrazoles as edg receptor agonists MERCK SHARP & DOHME CORP. 2005-01-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050020837-A1 N-(benzyl)aminoalkylcarboxylates, phosphinates, phosphonates and tetrazoles as edg receptor agonists EDNRA, ADGRE5, GPR65 ALDH1A1 2747/4885HPGD 1389/4885PDK2 1840/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.